Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Benjamin

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Transfusion|February 22, 2021
Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reductionEmmanuel A Fadeyi, Stephen J Wagner, Corinne Goldberg, et al.
JAMA|February 2, 2006
Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South AfricaAnthon du P Heyns, Richard J Benjamin, J P Ronel Swanevelder, et al.
Transfusion|November 29, 2025
Amustaline/glutathione pathogen-reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trialIan J Welsby, Michael E Sekela, Edward L Snyder, et al.
Transfusion|July 21, 2021
A survey of US hospitals on platelet inventory management, transfusion practice, and platelet availabilitySuchitra Pandey, Geoffrey A Belanger, Srijana Rajbhandary, et al.
Transfusion|November 8, 2005
Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patientsRichard J Benjamin, Jeffrey McCullough, Paul D Mintz, et al.
Transfusion|October 2, 2019
Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 daysLaura Infanti, Andreas Holbro, Jakob Passweg, et al.
Transfusion|April 19, 2025
A novel acridine flow cytometry marker to track post-transfusion amustaline/glutathione pathogen-reduced red blood cell survival in sickle cell disease patientsRichard J Benjamin, John P Pitman, Christopher Karim, et al.
Transfusion|March 5, 2020
Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United StatesChristina L Dean, Jay W Hooper, John M Dye, et al.
Transfusion|May 6, 2009
Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safetyAnne F Eder, Jean M Kennedy, Beth A Dy, et al.
Transfusion|November 17, 2007
Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donationsRichard J Benjamin, Michael P Busch, Chyang T Fang, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Transfusion|February 22, 2021
Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reductionEmmanuel A Fadeyi, Stephen J Wagner, Corinne Goldberg, et al.
JAMA|February 2, 2006
Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South AfricaAnthon du P Heyns, Richard J Benjamin, J P Ronel Swanevelder, et al.
Transfusion|November 29, 2025
Amustaline/glutathione pathogen-reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trialIan J Welsby, Michael E Sekela, Edward L Snyder, et al.
Transfusion|July 21, 2021
A survey of US hospitals on platelet inventory management, transfusion practice, and platelet availabilitySuchitra Pandey, Geoffrey A Belanger, Srijana Rajbhandary, et al.
Transfusion|November 8, 2005
Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patientsRichard J Benjamin, Jeffrey McCullough, Paul D Mintz, et al.
Transfusion|October 2, 2019
Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 daysLaura Infanti, Andreas Holbro, Jakob Passweg, et al.
Transfusion|April 19, 2025
A novel acridine flow cytometry marker to track post-transfusion amustaline/glutathione pathogen-reduced red blood cell survival in sickle cell disease patientsRichard J Benjamin, John P Pitman, Christopher Karim, et al.
Transfusion|March 5, 2020
Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United StatesChristina L Dean, Jay W Hooper, John M Dye, et al.
Transfusion|May 6, 2009
Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safetyAnne F Eder, Jean M Kennedy, Beth A Dy, et al.
Transfusion|November 17, 2007
Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donationsRichard J Benjamin, Michael P Busch, Chyang T Fang, et al.
Pageof 9